UK Markets closed
NIKKEI 225
27,883.78 +365.53 (+1.33%) HANG SENG
20,192.40 +407.75 (+2.06%) CRUDE OIL
73.05 -0.15 (-0.20%) GOLD FUTURES
1,966.80 -6.70 (-0.34%) DOW
32,611.93 +217.68 (+0.67%) BTC-GBP
22,940.04 +1,153.00 (+5.29%)
CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:40PM EDT. Market open.
| Previous close | 1.5200 |
| Open | 1.5400 |
| Bid | 1.4900 x 1300 |
| Ask | 1.5000 x 800 |
| Day's range | 1.4600 - 1.5800 |
| 52-week range | 1.1700 - 3.0200 |
| Volume | |
| Avg. volume | 2,723,780 |
| Market cap | 98.796M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7130 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.82 |
- Simply Wall St.
What Does The Future Hold For CytomX Therapeutics, Inc. (NASDAQ:CTMX)? These Analysts Have Been Cutting Their Estimates
The analysts covering CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) delivered a dose of negativity to shareholders today...
- Zacks
CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -100% and 94.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 42% of the company
Key Insights Institutions' substantial holdings in CytomX Therapeutics implies that they have significant influence...
© 2023 Yahoo. All rights reserved.
